SCHEMBL8974261

SCHEMBL8974261

NS(=O)(=O)c1ccc(C2=CC(F)(F)C=C2c2ccc(Cl)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.60
CA9 Q16790 5/20 0.60
CA1 P00915 5/20 0.60
CA12 O43570 4/20 0.60
CA4 P22748 4/20 0.60
CA7 P43166 3/20 0.60
CA5A P35218 2/20 0.60
CA5B Q9Y2D0 2/20 0.60
CA3 P07451 1/20 0.60
CA6 P23280 1/20 0.60
CA13 Q8N1Q1 1/20 0.60
CA14 Q9ULX7 1/20 0.60
PTGS2 P35354 12/20 0.59
PTGS1 P23219 7/20 0.56
MAOA P21397 2/20 0.51
MAOB P27338 2/20 0.51
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8973874 0.85 PTGS2 (0.57) CA2CA9CA1CA12CA4
SCHEMBL8974128 0.83 PTGS2 (0.56) PTGS2PTGS1
SCHEMBL8974824 0.83 CA2 (0.60) CA2CA9CA1CA12CA4
SCHEMBL8974169 0.83 CA2 (0.55) CA2CA9CA1CA12CA4
SCHEMBL8974954 0.83 PTGS2 (0.55) CA2CA9CA1CA12CA4
SCHEMBL8974520 0.82 CA2 (0.54) CA2CA9CA1CA12CA14
SCHEMBL8974616 0.81 KIF11 (0.70) CA2CA9CA1CA12CA14
SCHEMBL6475078 0.80 CA2 (0.86) CA2CA9CA1CA12CA4
SCHEMBL8974240 0.80 PTGS2 (0.59) CA2CA9CA1CA12CA4
SCHEMBL8973810 0.80 PTGS2 (0.55) CA2CA9CA1CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed